Trials / Completed
CompletedNCT05138835
BOTOX® Cosmetic and Skin Health.
A Randomized, Double Blind Evaluation of the Effects of BOTOX® Cosmetic on Skin Health
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Andreas Nikolis · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This is a two cohort, randomized, double blind, single center study to evaluate the effects of Botox Cosmetic (BTX) on sebum protection. Thirty-four female subjects with moderate-to-high skin sebum concentration will be recruited and randomized in a 1:1 ratio to treatment groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Botox Cosmetic | BOTOX® Cosmetic is approved and commercially available for use in Canada. BOTOX® Cosmetic is a prescription medicine that is injected into muscles and used to temporarily improve the look of moderate to severe frown lines between the eyebrows, crow's feet lines, and forehead lines in adults. |
Timeline
- Start date
- 2021-11-11
- Primary completion
- 2022-11-11
- Completion
- 2022-12-11
- First posted
- 2021-12-01
- Last updated
- 2023-05-31
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05138835. Inclusion in this directory is not an endorsement.